Selling and marketing expenses increased $0.3 million, or 14%, primarily due to higher consulting fees associated with CMS reimbursement-related activity and travel expenses.

May 11, 2023 / CFO / receipt, needs a key / Mike Lawless, CFO | earnings call 2023-05-11 | transcript 0f6d8307-a1be-4b2e-bac8-c08ec5b86c67 | chars 13376-13550 | segment 14

Our third quarter of 2022 operating expenses 5.7 million as compared to 3.8 million in the prior year's quarter. Within R&D, this increase is attributable to higher consultants' activity on development projects, partially offset by some grant assistance from the Israel Innovation Authority. In sales and marketing, we also had an increase in spending, primarily due to higher consulting expenses related to CMS progress, sales-related expenditures for trade show activities since the COVID restrictions are being lifted, and personnel-related costs. General and administrative expenses also grew primarily from higher professional services associated with the expanded 2022 proxy process.

Nov 7, 2022 / CFO / receipt, needs a key / Mike Lawless, CFO | earnings call 2022-11-07 | transcript 28127639-a560-44b7-910a-f632c2db937b | chars 8126-8815 | segment 8